Taylor & Francis Group

SHERPA: Unknown

People

  1. Fleisher
    Fleisher
  2. Hassoun
    Hassoun
  3. Antonescu
    Antonescu
  4. Landau
    Landau
  5. Lin
    Lin
  6. Young
    Young

Groups

  1. Center for Hematologic Malignancies (4)
  2. Department of Medicine (4)
  3. Hematologic Malignancies, Division of (4)
  4. Bone Marrow Transplant (2)
  5. Myeloma (2)
  6. GSK Faculty (1)
  7. Pediatric Leukemia (1)
  8. Survivorship Research (1)
  9. Tow Center for Developmental Oncology (TCDO) (1)
Search Within
  1. "Raymond Comenzo"
Formats
  1. Meeting Abstract (8)
  2. Journal Article (1)
Groups
  1. Center for Hematologic Malignancies (4)
  2. Department of Medicine (4)
  3. Hematologic Malignancies, Division of (4)
  4. Bone Marrow Transplant (2)
  5. Myeloma (2)
  6. GSK Faculty (1)

More Groups

People
  1. Raymond Comenzo (9)
  2. Ping Zhou (7)
  3. Bradly Clark (4)
  4. Julie Feldstein (4)
  5. Martin Fleisher (4)
  6. Hani Hassoun (2)

More People

Years
  1. 2006 (7)
  2. 2001 (1)
  3. 2000 (1)
Publications
  1. Amyloid (8)
  2. Leukemia and Lymphoma (1)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The inhibitory Fc gamma-receptor IIB (CD32B) is highly expressed on clonal plasma cells from patients with systemic light-chain (AL) amyloidosis and provides a target for monoclonal antibody therapy
    Meeting Abstract

    Zhou, P.; Olshen, A. B.; Bonvini, E.; Koenig, S.; Fleisher, M.; Young, J.; Boruchov, A.; Comenzo, R. L.
    Amyloid (2006)

    Fulltext@MSK | Save
  • ApolipoproteinE3 associates with fibrils extracted from a patient with kappa light-chain AL amyloidosis
    Meeting Abstract

    Wang, L.; Zhou, P.; Clark, B.; Lampan, N.; Yuan, X.; Deng, H.; Comenzo, R. L.
    Amyloid (2006)

    Fulltext@MSK | Save
  • Overexpression of calreticulin in clonal AL plasma cells is associated with response to melphalan and autologous stem cell transplant in systemic light-chain (AL) amyloidosis
    Meeting Abstract

    Teruya-Feldstein, J.; Zhou, P.; Olshen, A. B.; Comenzo, R. L.
    Amyloid (2006)

    Fulltext@MSK | Save
  • AL amyloidosis in a patient with a T60A TTR mutation
    Meeting Abstract

    Landau, H.; Comenzo, R. L.; Zhou, P.; Clark, B.; Teruya-Feldstein, J.; Wang, S.; Murphy, C. L.; Solomon, A.
    Amyloid (2006)

    Fulltext@MSK | Save
  • A supervised analysis of gene-expression profiles of purified clonal plasma cells from patients with systemic light-chain amyloidosis (AL) who have high or low levels of serum free lambda light chains
    Meeting Abstract

    Comenzo, R. L.; Zhou, P.; Fleisher, M.; Olshen, A. B.
    Amyloid (2006)

    Fulltext@MSK | Save
  • Risk-adapted melphalan (MEL) with stem cell transplant (SCT) and adjuvant dexamethasone (D)+/- thalidomide (T) for AL patients achieves low treatment-related mortality (TRM) and high hematologic response rates
    Meeting Abstract

    Cohen, A. D.; Zhou, P.; Reich, L.; Hassoun, H.; Teruya-Feldstein, J.; Filippa, D. A.; Clark, B.; Stubblefield, M.; Fleisher, M.; Nimer, S. D.; more...
    Amyloid (2006)

    Fulltext@MSK | Save
  • Accuracy of the abdominal fat pad aspirate and ancillary test results in a patient population with a high prevalence rate of amyloidosis
    Meeting Abstract

    Clark, B.; Lin, O.; Moreira, A.; Teruya-Feldstein, J.; Antonescu, C.; Hassoun, H.; Zhou, P.; Fleisher, M.; Comenzo, R.
    Amyloid (2006)

    Fulltext@MSK | Save
  • The tropism of organ involvement in primary systemic amyloidosis: Contributions of Ig V-L germline gene use and clonal plasma cell burden
    Meeting Abstract

    Comenzo, R. L.; Zhang, Y.; Martinez, C.; Osman, K.; Herrera, G. A.
    Amyloid (2001)

    Fulltext@MSK | Save
  • Hematopoietic cell transplantation for primary systemic amyloidosis: What have we learned
    Journal Article

    Comenzo, R. L.
    Leukemia and Lymphoma (2000)

    Fulltext@MSK | Save